Filing Details
- Accession Number:
- 0001127602-19-026235
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-07 17:17:39
- Reporting Period:
- 2019-08-06
- Accepted Time:
- 2019-08-07 17:17:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238334 | Daniel Jonas | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | Evp Legal Affairs,Gen. Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-06 | 12,000 | $39.87 | 28,319 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-06 | 8,598 | $92.01 | 19,721 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2019-08-06 | 1,560 | $44.90 | 21,281 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-08-06 | 1,157 | $92.94 | 20,124 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2019-08-06 | 2,909 | $92.10 | 17,215 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2019-08-06 | 12,000 | $0.00 | 12,000 | $39.87 |
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2019-08-06 | 1,560 | $0.00 | 1,560 | $44.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,100 | 2026-03-01 | No | 4 | M | Direct | |
| 0 | 2024-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92 to $92.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Billionaire Hedge Funds
